𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term treatment with low doses of interferon ALFA-2B (rIFNa2b) in patients with chronic non-A, non-B (NANB) hepatitis: Data of a multicenter randomized prospectively controlled trial

✍ Scribed by Müller, R.; Baumgarten, R.; Markus, R.; Beckh, K.H.; Loeschke, K.; Stremmel, W.; Niederau, C.; Wiedmann, K.-H.; Weber, P.

Book ID
121986848
Publisher
Elsevier Science
Year
1990
Tongue
English
Weight
107 KB
Volume
11
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to higher doses of interferon a
Response to higher doses of interferon alfa-2b in patients with chronic hepatitis C: A randomized multicenter trial
✍ K L Lindsay; G L Davis; E R Schiff; H C Bodenheimer; L A Balart; J L Dienstag; R 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

JANICE ALBRECHT, 12 AND THE HEPATITIS INTERVENTIONAL THERAPY GROUP\* with continued therapy at that dose; however, a propor-To evaluate response rates to 3, 5, or 10 million units tion of patients who do not respond to 12 weeks of treat-(MU) of interferon alfa-2b, given thrice weekly, and to ment wi